Glomerular Disease in 2018: Where Are We Now, and Where Are We Going?

This activity will use case-based learning to highlight three important and complex glomerular diseases: membranous nephropathy, ANCA associated vasculitis and paraprotein-associated kidney disease. The presenters are experts who will review how recent advances have changed the paradigm of approaching these diseases, and how future research could revolutionize the way they are managed. Participants will gain an understanding of the use of biomarkers and novel, targeted therapies in these disorders.

Target Audience

  • Physicians 
  • Physician Assistants 
  • Nurse Practitioners
     

Learning Objectives

After participation in this activity, learners will be better able to:

  • Explain the approaches to the diagnosis of ANCA associated vasculitis, membranous nephropathy, and paraprotein-associated kidney disease
  • Describe first-line therapies for ANCA associated vasculitis, membranous nephropathy, and paraprotein-associated kidney disease
  • Recognize how current studies could impact the diagnosis and treatment of these disorders
Method of Participation:

Learners will review the materials on accreditation information, target audience, learning objectives, and disclosure information; complete the pre-test; review the video content; complete the post-test (minimum score of 70% required; learners will only have 3 attempts to pass the post-test) and evaluation to successfully earn credit.  

If you participated in the live symposium Workshop: Glomerular Disease in 2018 - Where are we Now, and Where are we Going? on April 11, 2018 and claimed credit, you should not claim credit for this endured activity.

Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 ANCC Nurse Contact Hours
  • 0.92 ANCC Pharmacology
  • 2.00 Attendance
  • 2.00 Category I Credit for Physician Assistants
Course opens: 
08/22/2018
Course expires: 
08/22/2020
Cost:
$35.00
Rating: 
0
Faculty Disclosures:

Andrew Bomback, MD, MPH
Assistant Professor of Medicine
Columbia University
New York, NY
Disclosure: Consulting fee: Chemocentryx, Achillion

Laurence Beck, MD, PHD
Associate Professor of Medicine
Boston University
Boston, MA
Disclosure: Research support: Pfizer CTI; Honorarium: Achillion Pharmaceuticals; Royalty: UpToDate, Inc. Boston University

Jonathan Hogan, MD
Assistant Professor
University of Pennsylvania
Haddonfield, NJ
Disclosure: Honoraria: Dimerix, Variant, GSK

Planning Committee Disclosures:

Jonathan Hogan, MD
Assistant Professor
University of Pennsylvania
Haddonfield, NJ
Disclosure: Honoraria: Dimerix, Variant, GSK

Joanna Hudson, Pharm.D.
Professor, UT Department of Clinical Pharmacy & Translational Science
The University of Tennessee College of Pharmacy
Memphis, TN
Disclosure: Has no financial relationships with commercial interest(s).

Lawrence Weisberg, MD, FNKF
Professor of Medicine, Chief of Nephrology, CMSRU
Cooper University Health Care
Camden, NJ
Disclosure: Consulting Fee: PLC Medical, Inc.

Danielle Nathan, MA
Senior Director, Professional Education
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Kathryn Troy, MPH
Professional Education Manager
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Declaration of Disclosure:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.


Unlabeled/Investigational Use:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

In support of improving patient care, the National Kidney Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician

The National Kidney Foundation designates this enduring activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistant 

The National Kidney Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. AAPA accepts Category I credit from AOACCME, prescribed credit from AAFP, and AMA Category I Credit(s)TM from organizations accredited by ACCME.  

Physician assistants may receive a maximum of 1.5 hours of Category I credit for completing this program.

Nurse Practitioner

Awarded 2.0 contact hours of continuing nursing education (includes .92 contact hours in the area of pharmacology).
 

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 ANCC Nurse Contact Hours
  • 0.92 ANCC Pharmacology
  • 2.00 Attendance
  • 2.00 Category I Credit for Physician Assistants

Accreditation Period

Course opens: 
08/22/2018
Course expires: 
08/22/2020

Price

Cost:
$35.00
Please login or register for a PERC account to take this course.
Disclaimer:

The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Required Hardware/software

System requirements can be found here.

Contact Information:

For any questions concerning this activity, please send an email to CMEinfo@kidney.org or call NKF at 1-800-622-9010.

To view NKF privacy and confidentiality policy as it relates to CME/CE activity, please visit http://www.kidney.org/

For additional professional education resources, contact NKF at 1-800-622-9010 or visit https://www.kidney.org/professionals